Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2012

Usubutun A, Mutter GL, Saglam A, Dolgun A, Ozkan EA, Ince T, et al. Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists. Mod Pathol. 2012;25(6):877-84.

Benassi B, Flavin R, Marchionni L, Zanata S, Pan Y, Chowdhury D, et al. MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. Cancer Discov. 2012;2(3):236-47.

Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, et al. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc Natl Acad Sci U S A. 2012;109(28):11252-7.

Scharf B, Clement CC, Wu X-, Morozova K, Zanolini D, Follenzi A, et al. Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris. Nat Commun. 2012;3:755.

Durand M, Robinson BD, Aronowitz E, Tewari AK, Ballon DJ. High-resolution magnetic resonance imaging of prostatectomy specimens: a promising tool for virtual histology. Eur Urol. 2012;62(5):938-40.

Huang T-, Sahasrabuddhe NA, Kim M-, Getnet D, Yang Y, Peterson JM, et al. Regulation of lipid metabolism by Dicer revealed through SILAC mice. J Proteome Res. 2012;11(4):2193-205.

Liu L, Cohen C, Siddiqui MT. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid. Acta Cytol. 2012;56(4):425-30.

Carter RL, Kang L, Darcy KM, Kauderer J, Liao S-, Rodgers WH, et al. A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study. Cancer Causes Control. 2012;23(12):2013-21.

Métais J-, Winkler T, Geyer JT, Calado RT, Aplan PD, Eckhaus MA, et al. BCL2A1a over-expression in murine hematopoietic stem and progenitor cells decreases apoptosis and results in hematopoietic transformation. PLoS One. 2012;7(10):e48267.

Cooper N, Stasi R, Cunningham-Rundles S, Cesarman E, McFarland JG, Bussel JB. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia. Br J Haematol. 2012;158(4):539-47.